JP2018525417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018525417A5 JP2018525417A5 JP2018510483A JP2018510483A JP2018525417A5 JP 2018525417 A5 JP2018525417 A5 JP 2018525417A5 JP 2018510483 A JP2018510483 A JP 2018510483A JP 2018510483 A JP2018510483 A JP 2018510483A JP 2018525417 A5 JP2018525417 A5 JP 2018525417A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- composition
- day
- patient
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022110221A JP2022133453A (ja) | 2015-08-25 | 2022-07-08 | 幹細胞移植方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562209721P | 2015-08-25 | 2015-08-25 | |
| US62/209,721 | 2015-08-25 | ||
| PCT/US2016/048738 WO2017035375A1 (en) | 2015-08-25 | 2016-08-25 | Methods for stem cell transplantation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110221A Division JP2022133453A (ja) | 2015-08-25 | 2022-07-08 | 幹細胞移植方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018525417A JP2018525417A (ja) | 2018-09-06 |
| JP2018525417A5 true JP2018525417A5 (https=) | 2019-10-03 |
| JP7105188B2 JP7105188B2 (ja) | 2022-07-22 |
Family
ID=58101080
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018510483A Active JP7105188B2 (ja) | 2015-08-25 | 2016-08-25 | 幹細胞移植方法 |
| JP2022110221A Pending JP2022133453A (ja) | 2015-08-25 | 2022-07-08 | 幹細胞移植方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022110221A Pending JP2022133453A (ja) | 2015-08-25 | 2022-07-08 | 幹細胞移植方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190183930A1 (https=) |
| EP (2) | EP4458953A3 (https=) |
| JP (2) | JP7105188B2 (https=) |
| KR (2) | KR20180041229A (https=) |
| CN (2) | CN108025023A (https=) |
| AU (2) | AU2016312610B2 (https=) |
| CA (1) | CA2996522A1 (https=) |
| ES (1) | ES2984387T3 (https=) |
| IL (1) | IL257678B2 (https=) |
| WO (1) | WO2017035375A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108025023A (zh) * | 2015-08-25 | 2018-05-11 | Uab研究基金会 | 用于干细胞移植的方法 |
| AU2017234010B2 (en) * | 2016-03-14 | 2024-06-13 | Millennium Pharmaceuticals, Inc. | Methods of treating or preventing graft versus host disease |
| US11421005B2 (en) | 2016-12-09 | 2022-08-23 | The Uab Research Foundation | Chimeric chlorotoxin receptors |
| EP4417210A1 (en) * | 2017-03-15 | 2024-08-21 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| BR112019026498A2 (pt) * | 2017-06-14 | 2020-07-14 | Adc Therapeutics Sa | regimes de dosagem para a administração de um adc anti-cd25 |
| EP3749334B1 (en) | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| CA3114292A1 (en) * | 2018-09-27 | 2020-04-02 | Phosphogam, Inc. | Methods and compositions for the expansion and use of allogeneic gamma/delta-t cells |
| KR20200145328A (ko) | 2019-06-21 | 2020-12-30 | 안혜빈 | 자동 물분사 칠판지우개 |
| JP2023500277A (ja) * | 2019-11-05 | 2023-01-05 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | Ｔ細胞媒介性自己免疫疾患の治療におけるベト細胞の使用 |
| US12496303B2 (en) | 2020-10-19 | 2025-12-16 | Washington University | Conditioning agents for use in allogeneic hematopoietic stem cell transplantation |
| WO2025122271A1 (en) * | 2023-12-08 | 2025-06-12 | IN8bio, Inc. | Methods of allogeneic hematopoietic stem cell transplantation and cancer treatment |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0699235B1 (en) * | 1993-05-17 | 2007-05-09 | Yeda Research And Development Company, Ltd. | Animal model for hepatitis virus infection |
| EP1147186A4 (en) * | 1999-01-28 | 2002-05-15 | Palmetto Health Alliance D B A | In vitro activated gamma delta lymphocytes |
| US7078034B2 (en) * | 1999-01-28 | 2006-07-18 | Palmetto Health Alliance | In vitro activated γ δ lymphocytes |
| WO2003012060A2 (en) * | 2001-08-01 | 2003-02-13 | Jewish Hospital Healthcare Services, Inc. | Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd |
| EP1790664A1 (en) * | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| KR20100127277A (ko) * | 2008-03-15 | 2010-12-03 | 에스엠티. 쥐 알 도시 앤드 에스엠티. 케이 엠 메타 인스티튜드 오브 키드니디지즈 앤드 리서치 센트레 | 이식면역 관용을 유도하기 위한 줄기 세포 조성물 |
| EP2593098A4 (en) * | 2010-07-16 | 2014-02-05 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY |
| KR101551555B1 (ko) * | 2011-03-17 | 2015-09-08 | 밀테니 비오텍 게앰베하 | Tcr 알파/베타가 고갈된 세포 제제 |
| PT2710123T (pt) * | 2011-05-19 | 2017-10-13 | Inst De Medicina Molecular | Linha celular de linfócitos compreendendo células t gama-delta, método de composição e produção resultante dos mesmos |
| WO2012171007A2 (en) * | 2011-06-09 | 2012-12-13 | University Of Florida Research Foundation, Inc. | Methods for treating or preventing graft versus host disease |
| US9556271B2 (en) * | 2011-12-01 | 2017-01-31 | The Brigham And Women's Hospital, Inc. | Anti-CEACAM1 recombinant antibodies for cancer therapy |
| JP2015504047A (ja) * | 2011-12-22 | 2015-02-05 | イェダ リサーチ アンド デベロップメント カンパニー リミテッド | 安定かつ長期の生着のための併用療法 |
| EP3060059A4 (en) * | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
| CN103834615A (zh) * | 2014-03-27 | 2014-06-04 | 叶永清 | 一种适用于培养γδT细胞的无血清培养基 |
| CN108025023A (zh) * | 2015-08-25 | 2018-05-11 | Uab研究基金会 | 用于干细胞移植的方法 |
| ES2983739T3 (es) * | 2016-08-18 | 2024-10-24 | Uab Res Found | Composiciones y procedimientos para la inmunoterapia del cáncer |
-
2016
- 2016-08-25 CN CN201680053465.0A patent/CN108025023A/zh active Pending
- 2016-08-25 ES ES16840139T patent/ES2984387T3/es active Active
- 2016-08-25 EP EP24156525.8A patent/EP4458953A3/en active Pending
- 2016-08-25 AU AU2016312610A patent/AU2016312610B2/en active Active
- 2016-08-25 CA CA2996522A patent/CA2996522A1/en active Pending
- 2016-08-25 IL IL257678A patent/IL257678B2/en unknown
- 2016-08-25 EP EP16840139.6A patent/EP3340997B1/en active Active
- 2016-08-25 JP JP2018510483A patent/JP7105188B2/ja active Active
- 2016-08-25 WO PCT/US2016/048738 patent/WO2017035375A1/en not_active Ceased
- 2016-08-25 KR KR1020187008284A patent/KR20180041229A/ko not_active Ceased
- 2016-08-25 US US15/754,973 patent/US20190183930A1/en not_active Abandoned
- 2016-08-25 CN CN202210691597.3A patent/CN115137752A/zh active Pending
- 2016-08-25 KR KR1020257010284A patent/KR20250048489A/ko active Pending
-
2022
- 2022-03-10 US US17/691,477 patent/US20220265720A1/en active Pending
- 2022-07-08 JP JP2022110221A patent/JP2022133453A/ja active Pending
-
2023
- 2023-05-11 AU AU2023202946A patent/AU2023202946A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018525417A5 (https=) | ||
| JP2018193377A5 (https=) | ||
| JP2015522573A5 (https=) | ||
| JP2017533925A5 (https=) | ||
| WO2015181641A3 (en) | Combination of lenalidomide or pomalidomide and cd38 antibody-attenuated interferon-alpha constructs, and the use thereof | |
| JP2014530874A5 (https=) | ||
| JP2016535795A5 (https=) | ||
| WO2015157559A3 (en) | 10',11'-modified saxitoxins useful for the treatment of pain | |
| WO2016134223A3 (en) | Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof | |
| JP2014114295A5 (https=) | ||
| RU2014142267A (ru) | Лекарственное средство для лечения острого миелоидного лейкоза (омл) | |
| JP2016539157A5 (https=) | ||
| FI3383385T4 (fi) | Melflufeeniannoskuureja syöpään | |
| RU2015114566A (ru) | Способы лечения гепатита с | |
| EA031643B1 (ru) | Применение тасквинимода для лечения острого лимфобластного лейкоза и острого миелоидного лейкоза | |
| MX2018000240A (es) | Metodos para tratar el vhc. | |
| MX2016012722A (es) | Metodos para tratar el virus de la hepatitis c. | |
| JP2016527292A5 (https=) | ||
| RU2012136775A (ru) | Способ и средство для повышения адаптивных возможностей организма спортсменов в период тренировочного процесса | |
| RU2018102351A (ru) | Производные пиридин-3-ил уксусной кислоты в качестве ингибиторов репликации вируса иммунодефицита человека | |
| RU2014144404A (ru) | Железо (iii)-пиразин-комплексные соединения для лечения и профилактики явлений дефицита железа в организме и железодефицитной анемии | |
| RU2012114097A (ru) | Терапевтический агент против хронической боли | |
| RU2015133365A (ru) | Альфа-2 адренергический агонист для лечения внутриглазного давления и заболеваний глаз путем введения в стекловидное тело и внутрикамерно | |
| WO2006089120A3 (en) | Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury | |
| Koop | Intramuscular calcifications: case report |